Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)----a Pilot Study
Latest Information Update: 01 Oct 2024
At a glance
- Drugs Alirocumab (Primary) ; Atorvastatin
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms EAST-aICAS
Most Recent Events
- 15 Aug 2024 Trial design discussed in an article published in Clinical Neurology and Neurosurgery
- 18 Dec 2023 Planned End Date changed from 31 Jul 2024 to 31 Dec 2024.
- 18 Dec 2023 Planned primary completion date changed from 30 Jun 2024 to 31 Dec 2024.